FdaApplication
ANDA 211395
Identifiers
- fda_app_no: ANDA211395
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2024-03-22 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEFERASIROX | DEFERASIROX | 90MG | TABLET;ORAL |
| DEFERASIROX | DEFERASIROX | 180MG | TABLET;ORAL |
| DEFERASIROX | DEFERASIROX | 360MG | TABLET;ORAL |
3 products